What is the duration of brain zaps after discontinuing Celexa (citalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration of Brain Zaps After Celexa (Citalopram) Discontinuation

Brain zaps after discontinuing Celexa typically last from several days to a few weeks, though in rare cases they can persist for months or even years without effective treatment available. 1, 2

Timeline and Characteristics

  • Onset timing: Brain zaps typically begin within days after discontinuation, with the timing correlating to the medication's half-life—citalopram has a moderate half-life of approximately 35 hours, so symptoms usually emerge within 2-5 days of stopping 3

  • Typical duration: Most patients experience brain zaps transiently for days to weeks, with symptoms gradually resolving as the body readapts to the absence of the medication 1, 2

  • Prolonged cases: A small subset of patients report disabling brain zaps lasting months to years, representing a significant quality-of-life burden with no established effective treatment 2

Key Clinical Features

Symptom profile associated with citalopram discontinuation includes:

  • Dizziness (44% of cases) 4
  • Muscle tension (44%) 4
  • Chills (44%) 4
  • Confusion or trouble concentrating (40%) 4
  • The characteristic "brain zap" sensation itself—often described as electrical shock-like sensations 3, 2

Unique trigger: Lateral eye movements frequently trigger or worsen brain zaps, an unexpected finding that emerged strongly in discontinuation studies 3, 2

Risk Factors for Prolonged Symptoms

  • Higher doses: Patients taking higher doses of citalopram have significantly increased risk of antidepressant discontinuation syndrome (ADS) 4

  • Higher plasma concentrations: Elevated plasma levels at discontinuation correlate with worse ADS symptoms 4

  • Abrupt cessation: Sudden discontinuation dramatically increases both the severity and duration of brain zaps compared to gradual tapering 3, 2

Prevention Strategy

Very slow tapering is recommended for all patients discontinuing citalopram to minimize the risk and duration of brain zaps 4:

  • Taper over weeks to months rather than days 1
  • Reduce by 25% of the current dose every 1-2 weeks as a standard approach 5
  • Some patients may require even slower tapers (10% or less of the most recent dose each month) 6
  • All SSRIs should be slowly tapered when discontinued due to withdrawal risk 5

Management if Brain Zaps Occur

  • Restart and re-taper: If significant discontinuation symptoms develop, restart the prior dose of citalopram and then taper even more slowly 1

  • Symptomatic management: Provide additional symptomatic support as needed, though no specific effective treatment for brain zaps has been established 1, 2

  • Patient education: Inform patients that while distressing, brain zaps are typically self-limited, though the exact duration cannot be precisely predicted for individual patients 1, 2

Critical Caveat

The medical literature reveals a concerning gap: patients frequently report inability to obtain effective help from prescribers for brain zaps, and the perceived lack of medical interest in this symptom risks damaging the therapeutic relationship 2. Acknowledging the reality of this symptom and providing supportive management is essential even when definitive treatment options are limited.

References

Research

Discontinuing antidepressants: Pearls and pitfalls.

Cleveland Clinic journal of medicine, 2022

Research

Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.

The primary care companion for CNS disorders, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.